The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study

OBJECTIVE: Among treatment options for coronavirus infectious disease 2019 (COVID-19), well-studied oral medications are limited. We conducted a multicenter non-randomized, uncontrolled single-arm prospective study to assess the efficacy and safety of favipiravir for patients with COVID-19. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagisawa, Kunio, Takara, Katsuhiko, Suga, Hiroyuki, Saito, Akio, Hayashi, Toshimasa, Igarashi, Tsuneo, Tomizawa, Sachi, Saito, Etsuko, Sumiyoshi, Hisako, Ohyama, Yoshiaki, Tokue, Yutaka, Nakamura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683820/
https://www.ncbi.nlm.nih.gov/pubmed/35945028
http://dx.doi.org/10.2169/internalmedicine.9691-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683820/
https://www.ncbi.nlm.nih.gov/pubmed/35945028
http://dx.doi.org/10.2169/internalmedicine.9691-22

Ejemplares similares